Tyra Biosciences, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
RA CAPITAL MANAGEMENT, L.P. | 02/14/2025 | 10.64 M | $147.86 M | 2.12% | 18.07% |
CANAAN PARTNERS XI LLC | 01/21/2025 | 4.18 M | $58.10 M | -5.22% | 7.10% |
02/05/2025 | 4.08 M | $56.72 M | 100.00% | 6.93% | |
NEXTECH INVEST LTD. | 02/14/2025 | 4.06 M | $56.38 M | 0.00% | 6.89% |
BVF INC/IL | 02/14/2025 | 3.94 M | $54.82 M | -15.38% | 6.70% |
FMR LLC | 02/13/2025 | 3.11 M | $43.20 M | -7.85% | 5.28% |
02/14/2025 | 2.03 M | $28.18 M | 100.00% | 3.44% | |
TCG CROSSOVER MANAGEMENT, LLC | 02/14/2025 | 1.99 M | $27.65 M | 0.00% | 3.38% |
JANUS HENDERSON GROUP PLC | 02/14/2025 | 1.75 M | $24.29 M | 63.64% | 2.97% |
BLACKROCK FUNDING, INC. /DE | 02/07/2025 | 1.72 M | $23.89 M | 13.34% | 2.92% |
ORBIMED ADVISORS LLC | 02/14/2025 | 1.47 M | $20.43 M | 91.26% | 2.50% |
VANGUARD GROUP INC | 02/11/2025 | 1.21 M | $16.79 M | -3.02% | 2.05% |
FARALLON CAPITAL MANAGEMENT LLC | 02/14/2025 | 1.00 M | $13.91 M | 100.00% | 1.70% |
VESTAL POINT CAPITAL, LP | 02/14/2025 | 990,000 | $13.76 M | 100.00% | 1.68% |
5AM VENTURE MANAGEMENT, LLC | 02/14/2025 | 939,298 | $13.06 M | 0.00% | 1.60% |
KYNAM CAPITAL MANAGEMENT, LP | 02/14/2025 | 530,478 | $7.37 M | 13.36% | 0.90% |
GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 517,578 | $7.20 M | -1.07% | 0.88% |
PICTET ASSET MANAGEMENT HOLDING SA | 02/12/2025 | 354,012 | $4.92 M | 100.00% | 0.60% |
MILLENNIUM MANAGEMENT LLC | 02/14/2025 | 315,141 | $4.38 M | 2,900.20% | 0.54% |
SIO CAPITAL MANAGEMENT, LLC | 02/14/2025 | 240,870 | $3.35 M | -39.91% | 0.41% |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 02/14/2025 | 200,000 | $2.78 M | 0.00% | 0.34% |
ALLY BRIDGE GROUP (NY) LLC | 02/14/2025 | 175,063 | $2.43 M | -35.18% | 0.30% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/06/2025 | 170,600 | $2.37 M | -1.81% | 0.29% |
POLAR ASSET MANAGEMENT PARTNERS INC. | 02/25/2025 | 111,107 | $1.54 M | 26.11% | 0.19% |
CUBIST SYSTEMATIC STRATEGIES, LLC | 02/14/2025 | 109,748 | $1.53 M | 100.00% | 0.19% |
NANTAHALA CAPITAL MANAGEMENT, LLC | 02/14/2025 | 100,000 | $1.39 M | 100.00% | 0.17% |
WELLINGTON MANAGEMENT GROUP LLP | 02/12/2025 | 94,859 | $1.32 M | 4.44% | 0.16% |
JPMORGAN CHASE & CO | 02/12/2025 | 91,115 | $1.27 M | -75.28% | 0.15% |
02/13/2025 | 85,020 | $1.18 M | 100.00% | 0.14% | |
OPPENHEIMER & CO INC | 02/05/2025 | 75,439 | $1.05 M | -1.78% | 0.13% |
STATE OF WISCONSIN INVESTMENT BOARD | 02/14/2025 | 65,039 | $904,042 | 82.87% | 0.11% |
GOLDMAN SACHS GROUP INC | 02/11/2025 | 64,110 | $891,129 | -28.03% | 0.11% |
WALLEYE CAPITAL LLC | 02/13/2025 | 62,980 | $875,422 | -50.25% | 0.11% |
IKARIAN CAPITAL, LLC | 02/14/2025 | 60,000 | $834,000 | 100.00% | 0.10% |
VICTORY CAPITAL MANAGEMENT INC | 02/06/2025 | 56,640 | $787,296 | 88.30% | 0.10% |
RAYMOND JAMES FINANCIAL INC | 02/13/2025 | 54,783 | $761,483 | 100.00% | 0.09% |
MARSHALL WACE, LLP | 02/13/2025 | 54,077 | $751,671 | 175.71% | 0.09% |
NUVEEN ASSET MANAGEMENT, LLC | 02/14/2025 | 49,998 | $694,972 | 0.00% | 0.08% |
UBS GROUP AG | 02/14/2025 | 47,851 | $665,129 | 336.44% | 0.08% |
TWO SIGMA INVESTMENTS, LP | 02/14/2025 | 46,269 | $643,139 | 18.11% | 0.08% |
BANK OF NEW YORK MELLON CORP | 02/04/2025 | 45,007 | $625,597 | 5.19% | 0.08% |
BARCLAYS PLC | 02/13/2025 | 43,070 | $599,000 | 14.47% | 0.07% |
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 02/14/2025 | 39,093 | $543,393 | 100.00% | 0.07% |
DIMENSIONAL FUND ADVISORS LP | 02/13/2025 | 37,981 | $527,937 | 283.38% | 0.06% |
UBS ASSET MANAGEMENT AMERICAS INC | 02/14/2025 | 35,635 | $495,326 | 41.36% | 0.06% |
RENAISSANCE TECHNOLOGIES LLC | 02/13/2025 | 29,100 | $404,490 | 100.00% | 0.05% |
RHUMBLINE ADVISERS | 01/30/2025 | 26,202 | $364,200 | 4.08% | 0.04% |
HIGHVISTA STRATEGIES LLC | 02/14/2025 | 23,941 | $332,780 | 48.91% | 0.04% |
AMERICAN CENTURY COMPANIES INC | 02/11/2025 | 22,142 | $307,774 | -48.51% | 0.04% |
AUOUR INVESTMENTS LLC | 02/03/2025 | 21,020 | $303,949 | 0.00% | 0.04% |
Tyra Biosciences, Inc. institutional Ownership - FAQ's
During the previous two years, 119 institutional investors and hedge funds held shares of Tyra Biosciences, Inc.. The most heavily invested institutionals were:
RA CAPITAL MANAGEMENT, L.P.: 10.64 M
Canaan Partners XI LLC: 4.18 M
Nextech Invest Ltd.: 4.06 M
BVF INC/IL: 3.94 M
FMR LLC: 3.11 M
TCG Crossover Management, LLC: 1.99 M
82.57% of Tyra Biosciences, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 49.56 M shares in the last 24 months. This purchase volume represents approximately $795.96 M in transactions.